See the DrugPatentWatch profile for Alglucosidase
What is the price of alglucosidase alfa?
No specific market price (per vial/infusion) is provided in the available source material. Because alglucosidase alfa (Lumizyme) pricing can vary by country, treatment regimen, and payer (including hospital contract pricing), the exact “price” is usually not publicly posted as a single number.
How do patients and payers usually get alglucosidase alfa pricing?
In practice, pricing is typically determined through manufacturer/provider channels and payer contracting rather than a one-size-fits-all list price. To get an accurate figure for a specific location, the usual routes are:
- Requesting pricing through the prescriber’s hospital pharmacy or specialty pharmacy
- Checking local national drug pricing databases (country-specific)
- Asking the insurer or the manufacturer’s reimbursement support for the patient’s coverage and expected out-of-pocket costs
Does the dose affect the total cost?
Yes. Alglucosidase alfa is dosed by weight and is given as an intravenous infusion on an ongoing schedule, so the total monthly or annual treatment cost depends heavily on a patient’s body weight and treatment duration. Even when per-unit pricing is known, total cost estimates change with dosing.
What if you mean “cost in the US” vs “in another country”?
Prices differ widely by market and by whether you’re asking about:
- Manufacturer list price
- Contracted/payer-negotiated price
- Patient out-of-pocket cost after insurance
- Total cost of care (drug plus infusion/admin supplies)
If you tell me the country (and whether you want list price, insured cost, or out-of-pocket), I can tailor the answer to the right kind of pricing figure.
Is there an alternative that changes cost?
Other enzyme replacement therapies for Pompe disease (including agalsidase options depending on context, and newer regimen options where applicable) can change both drug cost and total treatment cost. Whether an alternative is available and affordable depends on country approval status and payer coverage.
Which product name should I use for pricing searches?
Alglucosidase alfa is marketed as Lumizyme (and in some contexts may be referenced by its generic name). Using both names helps locate country-specific pricing information.
Sources
No sources were provided with the question, so I could not cite any specific pricing data.